Freeman Jonathan E has filed 4 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 16600 shares of Phio Pharmaceuticals Corp. ($PHIO) on February 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2026 | Phio Pharmaceuticals Corp. | $PHIO | Freeman Jonathan E | Director | A | Common Stock, $.0001 par value | 16600 | $0.00 | 32,655.0000 | 10,764,428 | 103.39% | 0.15% |
| Sept. 11, 2025 | Phio Pharmaceuticals Corp. | $PHIO | Freeman Jonathan E | Director | A | Common Stock, $.0001 par value | 14700 | $0.00 | 16,055.0000 | 4,778,154 | 1084.87% | 0.31% |
| Sept. 11, 2024 | Phio Pharmaceuticals Corp. | $PHIO | Freeman Jonathan E | Director | A | Common Stock, $0.0001 par value | 1000 | $0.00 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | Phio Pharmaceuticals Corp. | $PHIO | Freeman Jonathan E | Director | A | Common stock, $0.0001 par value | 1500 | $0.00 | 3,197.0000 | 0 | 88.39% | 0.00% |